原发性玻璃体视网膜淋巴瘤一例

2017-12-03 佚名 中华眼底病杂志

患者女,58岁。

【一般资料】

患者女,58岁。

【主诉】

因左眼视物不清1个月,加重1周于2015年12月5日来我院就诊

【现病史】

1个月前因左眼视力下降在外院就诊,荧光素眼底血管造影(FFA)检查考虑为左眼视网膜静脉阻塞,给予活血化瘀药物治疗;1周前因左眼青光眼给予降眼压药物治疗,眼胀缓解,但视物仍模糊。头颅CT检查未见明显异常。为进一步诊治转入我院。

【体格检查】

右眼视力1.0,左眼视力0.25,不能矫正。左眼角膜后沉着(+),玻璃体混浊(+)。眼底视盘肿胀,边界不清楚;后极部视网膜动脉部分呈白线,视网膜可见出血、渗出,未见明显隆起灶(图1A)。右眼眼前节正常,晶状体轻度混浊;玻璃体透明。眼底赤道部视网膜色素改变(图1B)。



【辅助检查】

FFA检查,左眼后极部视网膜豹点状弱荧光改变,视盘强荧光(图1C);右眼散在视网膜下点状强荧光,晚期未见荧光素渗漏(图1D)。光相干断层扫描(OCT)检查,左眼视网膜色素上皮(RPE)下可见强反射信号(图2)。B型超声检查,左眼玻璃体混浊。右眼OCT、B型超声检查未见明显异常。



【初步诊断

左眼葡萄膜炎;左眼视网膜血管炎?右眼RPE改变。

【治疗】

015年12月25日复诊,诉左眼已视物不见,时有疼痛。检查:左眼视力光感。玻璃体混浊较前明显加重。实验室检查,血清抗链球菌溶血素“O”试验204IU/ml,其余血清感染性、风湿免疫指标均未见异常。患者转上级医院仍未明确诊断。2016年2月26日再次来院复诊。检查:左眼视力无光感。玻璃体重度混浊;眼底不能窥入。4月27日患者因阵发性头痛伴右侧肢体乏力1周就诊于我院神经外科。头颅MRJ检查,胼胝体压部及左侧顶叶深部可见多发明显均匀强化团块,范围约70mm×l7mm,边界清晰,周围可见大片水肿;其余脑室系统大小形态未见异常,脑中线结构无移位(图3)。诊断:胼胝体压部及左侧顶叶深部占位,淋巴瘤可能。行神经导航下经皮穿刺脑活检手术。病理诊断:弥漫性大B细胞性恶性淋巴瘤(图4)。转血液科行骨髓穿刺、PET-CT、肠镜等检查,结果均未见异常。临床诊断:原发性中枢神经系统弥漫性大B细胞淋巴瘤(PCNSL)。给予大剂量甲氨蝶呤治疗。2016年10月患者死亡。结合患者全身病情以及病理检查结果,修正完善眼科诊断:双眼原发性玻璃体视网膜淋巴瘤(PVRL)。




版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1846610, encodeId=00db1846610d0, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sun Jul 08 20:20:00 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269980, encodeId=a0711269980f2, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Dec 05 09:20:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496217, encodeId=87f6149621ecc, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68587, encryptionId=bab46858ee3, topicName=玻璃体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47bd9248134, createdName=yykkxiaodou, createdTime=Tue Dec 05 09:20:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266512, encodeId=4baf266512e1, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Sun Dec 03 18:48:36 CST 2017, time=2017-12-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1846610, encodeId=00db1846610d0, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sun Jul 08 20:20:00 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269980, encodeId=a0711269980f2, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Dec 05 09:20:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496217, encodeId=87f6149621ecc, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68587, encryptionId=bab46858ee3, topicName=玻璃体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47bd9248134, createdName=yykkxiaodou, createdTime=Tue Dec 05 09:20:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266512, encodeId=4baf266512e1, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Sun Dec 03 18:48:36 CST 2017, time=2017-12-03, status=1, ipAttribution=)]
    2017-12-05 zutt
  3. [GetPortalCommentsPageByObjectIdResponse(id=1846610, encodeId=00db1846610d0, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sun Jul 08 20:20:00 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269980, encodeId=a0711269980f2, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Dec 05 09:20:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496217, encodeId=87f6149621ecc, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68587, encryptionId=bab46858ee3, topicName=玻璃体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47bd9248134, createdName=yykkxiaodou, createdTime=Tue Dec 05 09:20:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266512, encodeId=4baf266512e1, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Sun Dec 03 18:48:36 CST 2017, time=2017-12-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1846610, encodeId=00db1846610d0, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sun Jul 08 20:20:00 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269980, encodeId=a0711269980f2, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Dec 05 09:20:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496217, encodeId=87f6149621ecc, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68587, encryptionId=bab46858ee3, topicName=玻璃体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47bd9248134, createdName=yykkxiaodou, createdTime=Tue Dec 05 09:20:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266512, encodeId=4baf266512e1, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Sun Dec 03 18:48:36 CST 2017, time=2017-12-03, status=1, ipAttribution=)]
    2017-12-03 飘飘爱

    很好

    0

相关资讯

双侧肾上腺腺瘤型原发性醛固酮增多症

图  T2WI磁共振影像[  A(左):右侧肾上腺肿瘤  B(右):左侧肾上腺肿瘤 ]     病例摘要   患者,男性,64岁,高血压20余年,3个月前出现头晕、肢体无力、周期性麻痹,昼间尿量800 ml,夜间尿量1000 ml。   血压为200/110 mmHg,血钾为2.4 mmo

国家卫生计生委办公厅关于印发原发性肝癌诊疗规范(2017年版)的通知

原发性肝癌是目前我国第四位的常见恶性肿瘤及第三位的肿瘤致死病因,严重威胁我国人民的生命和健康1,2。原发性肝癌主要包括肝细胞癌(Hepatocellular Carcinoma,HCC)、肝内胆管癌(Intrahepatic Cholangiocarcinoma,ICC)和HCC-ICC混合型三种不同病理类型,三者在发病机制、生物学行为、组织学形态、治疗方法以及预后等方面差异较大,其中肝细胞癌占到

常见的心脏原发性恶性肿瘤

最常见的心脏原发性恶性肿瘤是肉瘤,其又分为血管肉瘤、横纹肌肉瘤、纤维肉瘤、平滑肌肉瘤等。它们各自有何特点?

Lancet:原发性非小细胞肺癌远端指骨转移-案例分析

手部X线显示左中、右小指远节指骨为溶骨性病变(如图所示)。最近的PET扫描显示无胸外疾病。在缺乏创伤或感染的情况下,该患者被诊断为原发性肺癌溶骨性转移瘤,在左中指末节截肢后经组织学予以证实。术后功能良好,手指无持续疼痛。医务人员采用镇痛治疗右手小指。该患者几个月后死于原发疾病。

Chest:氯法齐明治疗原发性和难治性非结核分枝杆菌感染效果如何?

2017年10月,发表在《Chest》的一项由美国科学家进行的研究考察了氯法齐明治疗原发性和难治性非结核分枝杆菌(NTM)感染的安全性和有效性。

临床肝胆病杂志:原发性胆汁性胆管炎的临床特征与治疗分层管理

原发性胆汁性胆管炎(PBC)是一种异质性相对较强的疾病,不同患者的临床经过及表型可能存在较大差异。因此,必须给予长期的治疗和随访才能对患者进行准确的危险分层